Literature DB >> 19533073

[41-year old patient with obscure diarrhea].

T Brünnler1, F Bataille, F Hofstädter, G Birkenfeld, J Schölmerich.   

Abstract

Chronic inflammatory diseases can induce further complications such as secondary amyloidosis. Being a rare but serious complication it affects typically the kidneys resulting in a nephrotic syndrome. Further sites of AA amyloid deposition are liver, heart and the autonomic nervous system. We report about a patient with congenital neutropenia, AA amyloidosis and chronic intestinal bowel inflammation due to amyloid deposition in the bowel.

Entities:  

Mesh:

Year:  2009        PMID: 19533073     DOI: 10.1007/s00108-009-2341-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  22 in total

1.  Crohn's disease associated with autoimmune neutropenia.

Authors:  C Stevens; M A Peppercorn; R J Grand
Journal:  J Clin Gastroenterol       Date:  1991-06       Impact factor: 3.062

2.  The expanding spectrum of a disease. Behçet's disease associated with amyloidosis.

Authors:  I Tasdemir; B Sivri; C Turgan; S Emri; U Yasavul; S Caglar
Journal:  Nephron       Date:  1989       Impact factor: 2.847

Review 3.  Complement and function of neutrophils in chronic inflammatory bowel disease.

Authors:  J Elmgreen
Journal:  Dan Med Bull       Date:  1986-10

4.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

5.  Chromosomal breakage in Crohn's disease: anticlastogenic effect of D-penicillamine and L-cysteine.

Authors:  I Emerit; J Emerit; A Levy; M Keck
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

6.  Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.

Authors:  Gustaf Herlenius; Henryk E Wilczek; Marie Larsson; Bo-Göran Ericzon
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

7.  Superoxide production by Crohn's disease neutrophils.

Authors:  F T Curran; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

8.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

Authors:  R Kisilevsky; L J Lemieux; P E Fraser; X Kong; P G Hultin; W A Szarek
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

9.  Natural history and outcome in systemic AA amyloidosis.

Authors:  Helen J Lachmann; Hugh J B Goodman; Janet A Gilbertson; J Ruth Gallimore; Caroline A Sabin; Julian D Gillmore; Philip N Hawkins
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

10.  Eprodisate for the treatment of renal disease in AA amyloidosis.

Authors:  Laura M Dember; Philip N Hawkins; Bouke P C Hazenberg; Peter D Gorevic; Giampaolo Merlini; Irena Butrimiene; Avi Livneh; Olga Lesnyak; Xavier Puéchal; Helen J Lachmann; Laura Obici; Robert Balshaw; Denis Garceau; Wendy Hauck; Martha Skinner
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.